Rosy  Wills

Rosy Wills

Followers 0
Following 0
According to research report the global MIS Instruments Market is expected to grow from USD 20.1 billion in 2019 to USD 32.7 billion by 2025, at a CAGR of 8.5% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 The major companies in the global minimally invasive surgical instruments market include Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), B. Braun Melsungen AG (Germany), Smith & Nephew plc (US), Boston Scientific Corporation (US), and CONMED Corporation (US).The advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures across the globe are the key factors driving market growth.By type of surgery, the cardiothoracic surgery segment accounted for the largest share of the global MIS instruments market in 2018.The cardiothoracic surgery segment accounted for the largest share of the global MIS devices market in 2018.The large share of this segment can be attributed to the rising prevalence of cardiac diseases, growing awareness about the benefits of early detection of cardiovascular complications, the growing number of coronary and percutaneous cardiology interventions, and increasing adoption of MIS instruments owing to their convenience and better results as compared to other techniques.
According to research report the medical image management market is projected to reach USD 4.40 billion in 2023 from USD 3.04 billion in 2018 at a CAGR of 7.7% during the forecast period.Technological advancements in diagnostic imaging modalities and image management software, growing investments in the medical imaging market, government initiatives to encourage EMR adoption, increasing usage of imaging equipment, growing adoption of image management systems by small hospitals and imaging centers, and rapidly growing big data in healthcare are factors driving the growth of the medical image management system market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=240573338Based on procurement model, the enterprise PACS segment is projected to grow at the highest CAGR during the forecast period.By procurement model, the PACS market is segmented into departmental PACS and enterprise PACS.In 2018, the departmental PACS segment is estimated to account for the largest market share.This large share can be attributed to the fact that that PACS were originally designed keeping in mind individual departmental workflows and hence a large number of PACS were adopted in healthcare facilities.The PACS segment is expected to dominate the medical image management market in 2018.Based on product, the medical image management market is segmented into PACS, VNAs, AICA, and enterprise/universal viewers.The PACS segment is expected to account for the largest share of the market in 2018.Factors such as technological advancements in PACS; adoption of PACS in new imaging segments such as endoscopy, ophthalmology, mammography, and oncology; growing adoption of PACS by small hospitals and imaging centers; and government initiatives encouraging healthcare IT adoption are driving the growth of the PACS segment.The hospitals segment is expected to dominate the medical image management system market in 2018.The medical image management market is segmented on the basis of end users into hospitals, diagnostic imaging centers, and other end users including ambulatory surgical centers (ASCs), small clinics, and contract research organizations (CROs).
According to research report the global spinal implants market is projected to reach USD 13.8 billion by 2025 from USD 10.3 billion in 2019, at a CAGR of 5.0%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712The major players operating in the spinal implants and surgery devices market are Medtronic (Ireland), DePuy Synthes (US), NuVasive, Inc. (US), Stryker Corporation (US), B. Braun Melsungen AG (Germany), Zimmer Biomet Holdings, Inc. (US), Globus Medical, Inc. (US), Orthofix International N.V. (US), Abbott Laboratories (US), RTI Surgical, Inc. (US), Boston Scientific (US), SeaSpine Holdings Corporation (US), ulrich GmbH & Co. KG (Germany), Spineart (Switzerland), Kuros Biosciences AG (Switzerland), Bioventus, LLC (US), Colfax Corporation (US), Meditech Spine, LLC (US), and Implanet (France).Medtronic (Ireland) dominated the global spinal implants market in 2019, owing to its wide portfolio of spine surgery products and strong geographical presence across the globe.The company primarily focuses on developing technologically advanced products for minimally invasive spine surgeries.DePuy Synthes (US) held the second position in the global spinal implants and surgery devices market in 2019.The company has a strong geographical presence and offers a broad range of products that are integral to the spinal implants and surgical devices market.The company primarily focuses on strengthening its R capabilities to continuously develop and commercialize innovative spine products in the global spinal implants market.Market Growth Factors -Advancements in spine surgery technologies, increasing incidence of spinal disorders, the launch of advanced bone grafting products, and the increasing adoption of minimally invasive spine surgeries are the major factors driving the growth of this segment.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80546246 The Factors such as the rising awareness about oral hygiene, growing incidence of dental diseases, and technological advancements in oral care products are expected to drive the growth of the Oral Care Market.Opportunity: Increasing online purchase of Oral Care Products There has been a noticeable shift in the retailing of oral care products across the world in recent years.Online retailers are slowly being chosen over traditional distributors, retailers, and pharmacies.Buying oral care products through e-commerce portals offers several advantages, such as the accessibility of multi-brand oral care products at comparatively lower prices, ease of purchasing, and free shipping.Challenge: High Dependency on Retail/Consumer Stores Prominent players in the oral care market are highly reliant on on retail stores as they are the direct customers for manufacturers.More Details @ https://www.marketsandmarkets.com/Market-Reports/oral-care-market-80546246.html Recent Developments • In April 2020, GlaxoSmithKline Consumer Healthcare Limited (India) merged with Hindustan Unilever Limited (HUL), with HUL responsible for the distribution of GSK’s Consumer Healthcare brands in India, including its leading oral healthcare brand, Sensodyne.
The growth of the antibacterial susceptibility testing systems market is mainly driven by the growing number of hospitals across major markets, increasing awareness about diagnosis and the treatment of hospital-acquired infections coupled with the increasing adoption of rapid AST methods.Moreover, rising R investments by the key players operating in the market to develop genetics and genotyping-based AST solutions coupled with growing funding & grants for AST-related research are other important factors to drive the market growth in the near future.According to the new market research report Antimicrobial Susceptibility Testing Market is projected to reach USD 4.2 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 5.5% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984Based on type, the antibacterial susceptibility testing systems segment is expected to account for the largest share of the AST Market in 2019Based on type, the antibacterial susceptibility testing systems market has been segmented into the antibacterial susceptibility testing, antifungal susceptibility testing, antiparasitic susceptibility testing, and susceptibility testing types.The major share of the segment is attributed to the presence of regulatory guidelines to streamline the process of antibacterial susceptibility testing, technological advancements, and the rising burden of antibacterial resistance in developing as well as developed countries.The clinical diagnostics segment is expected to register the highest growth rate during the forecast periodBased on application, the antimicrobial susceptibility testing market has been segmented into the market is segmented into clinical diagnostics, drug discovery and development, epidemiology, and other applications.Significant market growth in the clinical diagnostics segment can be attributed to the rising burden of infectious diseases, the growing burden of antimicrobial resistance, and new product launches in the market.The susceptibility testing disks subsegment of manual antimicrobial susceptibility testing products to hold major market share by 2025Based on the product, the antimicrobial susceptibility testing market is segmented into automated laboratory instruments, manual antimicrobial susceptibility testing products, culture and growth media, and consumables.Among the manual antimicrobial susceptibility testing products, the susceptibility testing disks segment held a major share of the market in 2019.The high quality, low cost, and ease of use of these products are increasing the adoption of susceptibility testing disks in emerging countries.
The growth of the global Hemostasis Analyzer Market is largely driven by the increasing prevalence of cardiovascular diseases and blood disorders, technological advancements in coagulation analyzers, and the rising geriatric population.Emerging economies and growing number of reagent rental agreements are expected to offer growth opportunities to market players in the coming years.According to market research report the global Coagulation Analyzer Market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197226392Optical technology segment accounted for the largest share of the Coagulation Analyzer Market, by technology, in 2019The coagulation analyzers available in the market are based on three major technologies—optical technology, mechanical technology, and electrochemical technology.However, apart from these technologies, coagulation analyzers can also be based on other technologies, such as nephelometric, immunogenic, chromogenic, advanced biosensor, and thromboelastometry technologies.The most widely used technology in the Hemostasis Analyzer Market is the optical technology.This segment accounted for the largest share of the market in 2019.Clinical laboratories dominated the Coagulation Analyzer Market in 2019On the basis of end user, the Hemostasis Analyzer Market is segmented into clinical laboratories, hospitals, and other end users.In 2019, the clinical laboratories segment accounted for the largest share of the market.Clinical laboratory analyzers dominated the Coagulation Analyzer Market in 2019Based on product, the Hemostasis Analyzer Market is segmented into clinical laboratory analyzers and point-of-care testing analyzers.
Growth in this market is largely driven by the rising global incidence of respiratory diseases, increasing aging population, and the technological shift in spirometer devices towards smartphone-based data acquisition.According to the new market research report Spirometer Market is expected to reach $1,285 million by 2025 from $799 million in 2020, at a CAGR of 11.1%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18015659The consumables and accessoriessegment accounted for the largest share of the spirometer market, by product segment, in 2019Based on product, the spirometer products market is segmented into devices, consumables & accessories, and software.The consumables and accessories segment accounted for the largest share of the market in 2019.The rising incidence of respiratory diseases and the growing geriatric population are the key factors driving the growth of this product segment.Hospitals segment to register the highest growth rate in the Spirometry Market during the forecast period.Based on end user, the Spirometry Market is segmented into hospitals, clinical laboratories, home care settings, and industrial settings.The hospitals segment is expected to account for the highest share in 2019.Rapidly growing aging population, the increase in reimbursements for clinical tests performed in hospitals, and the launch of advanced spirometer devices are the factors driving the growth to this market during the forecasted period.spirometer products market Opportunity: Emerging economiesEmerging economies such as India, Brazil, China, and South Africa provide significant opportunities for players in the spirometry devices market.Of the top 20 most polluted cities in the world, 14 are in India.The use of spirometers for monitoring lung health is at a very low level in these countries.North America is the largest regional market for spirometer products marketThe global market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW).
Factors such as the rising incidence of lifestyle & cardiovascular diseases and increasing geriatric population are expected to propel the growth of the diagnostic electrocardiograph market.According to the new market research report ECG Market is expected to reach USD 10.3 billion by 2024 from USD 7.5 billion in 2019, at a CAGR of 6.4% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173The 3-lead ECG segment is expected to grow at the highest CAGR in the diagnostic ECG market during the forecast periodBy lead type, the diagnostic diagnostic electrocardiograph market is divided into 12-lead, 5-lead, 3-lead, 6-lead, single-lead, and other lead types (15- and 18-lead).The 3-lead segment is expected to grow at the highest CAGR during the forecast period.This positive growth is primarily due to the fact that these leads are used conjointly with various other cardiac diagnostic tests and during medical procedures.The hospitals, clinics, and cardiac centers segment accounted for the largest share of the diagnostic electrocardiograph market in 2018By end user, the market is classified into hospitals, clinics, and cardiac centers; ambulatory surgical centers; and other end users.In 2018, the hospitals, clinics, and cardiac centers segment accounted for the largest share of the market.The large share of this segment can primarily be attributed to the growing burden of cardiovascular diseases, which, in turn, is increasing the need for quality cardiology care.Asia Pacific diagnostic diagnostic electrocardiograph market is expected to grow at the highest CAGR during the forecast periodOn the basis of region, the diagnostic ECG market is segmented into North America, Europe, Asia Pacific, and RoW.
According to research report the global contrast media market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911Growth in the contrast agent market can primarily be attributed to factors such as the increasing prevalence of cancer & CVD, regulatory approval of a growing number of contrast agents, and the rising volume of CT & MRI examinations.However, the side effects and allergic reactions associated with contrast agents are expected to limit market growth to a certain extent.The prominent players in the global contrast media market include GE Healthcare (US), Bracco Imaging (Italy), Bayer (Germany), and Guerbet (France) are the major players operating in the market.Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules (India), J.B.Chemicals (India), Sanochemia (Austria), Taejoon Pharm (South Korea), Jodas (India), and Magnus Health (India).By type, the iodinated contrast media segment is expected to account for the largest share of the contrast media market in 2019Based on type, the contrast media market is segmented into iodinated contrast media, gadolinium-based contrast media, barium-based contrast media, and microbubble contrast media.In 2019, the iodinated contrast media segment is estimated to account for the largest share of the contrast media industry.The large share of this segment can be attributed due to its high usage in CT examinations coupled with the fact that it can be used in almost all body parts.By modality, the X-ray/CT segment is expected to account for the largest share of the market in 2019Based on modality, the market is segmented into X-ray/CT, MRI, and ultrasound procedures.
According to research report the global X-Ray Detectors Market is projected to reach USD 3.8 billion by 2024 from USD 2.8 billion in 2019, at a CAGR of 6.1% during the forecast period.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=7004984Factors such as growing public and private investments in digital imaging technologies, declining prices and benefits offered by digital detectors, and reimbursement cuts for analog X-rays are driving the growth of the X-ray detector market.The X-ray detectors market is highly consolidated in nature with several big and emerging players.Prominent players in this market include Varex Imaging Corporation (US), Thales Group (France), Canon, Inc. (Japan), Konica Minolta, Inc. (Japan), Hamamatsu Photonics K.K.(Japan), Teledyne DALSA Inc. (US), Fujifilm Holding Corporation (Japan), Agfa-Gevaert Group (Belgium), Carestream Health (US), Vieworks Co., Ltd (South Korea), Analogic Corporation (US), and Rayence (South Korea).These players have adopted various strategies such as acquisitions, partnerships, collaborations, and product launches to further expand their presence in the global X-ray detectors market.Acquisitions were the key growth strategies adopted by top players such as Varex Imaging Corporation (US), Canon, Inc. (Japan), Konica Minolta, Inc. (Japan), and Agfa-Gevaert Group (Belgium) from 2016 to 2018.The introduction of wireless X-ray detectors, growing medical tourism in developing countries, and the emerging markets are expected to offer significant growth opportunities for market players in the coming years.• Based on applications, the X-ray detectors market is segmented into medical applications, dental applications, security applications, veterinary applications, and industrial applications.The medical applications segment is expected to grow at the highest CAGR during the forecast period.• Based on panel size, the FPDs market is segmented into large-area FPDs and small-area FPDs.
According to research report the Elastography Imaging Market is expected to grow from USD 2.5 billion in 2018 to USD 4.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 11.0% during the forecast period.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107232051 The major driving factors in the elastography imaging market are growing incidence of breast cancer and chronic liver diseases, and a rising preference for minimally invasive procedures across the globe.The Asia Pacific elastography system market, particularly comprises Asian countries (such as India, China, South Korea, Japan, and Indonesia, among others) and Pacific countries (such as Australia, New Zealand, and Fiji, among others).Emerging Asia Pacific countries, such as India, China, Japan, South Korea, and Indonesia, are witnessing increasing per capita healthcare expenditure and rapid expansion and the modernization of their respective healthcare infrastructure.The hospitals, surgical & diagnostic centers segment, by end user, is projected to occupy the majority of the elastography system market share and grow at the fastest rate during the forecast period.Based on end user, the global elastography imaging market is segmented into hospitals, surgical & diagnostic centers; ambulatory surgical centers; and other end users.
According to research report the digital PCR qPCR market is projected to reach USD 6.3 billion by 2024 from USD 4.1 billion in 2019.The market is expected to grow at a CAGR of 8.8% from 2019 to 2024.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204 The growth of the digital PCR qPCR market is primarily driven by the rising incidences of target infectious diseases and genetic disorders, increasing financial support for research, and the increasing use of biomarker profiling in disease diagnostics.Companies in the digital PCR market are focusing on novel product development (including lab-on-chip devices, miniaturized devices, and microfluidics-based instruments) to cater to the growing end-user demand for technologically advanced dPCR and qPCR products.North America accounted for the largest share of the digital PCR qPCR market in 2019, followed by Europe.The large share of North American digital PCR qPCR market is mainly due to the rising number of genome-based drug development activities undertaken by US-based pharmaceutical and biotechnology companies, increasing support for the development of dPCR and qPCR technologies, a growing target patient base, and the focus on early and effective disease diagnosis.The global dPCR and qPCR industry offers significant growth potential for current and future players.The digital PCR market is consolidated in nature, with leading players acquiring small market players to gain their state-of-the-art PCR technologies and strengthen their market presence.This also helps them to strengthen their R and distribution network and penetrate markets in emerging nations.
According to market research report Veterinary Dental Equipment Market is projected to reach USD 490 million by 2023 from USD 329 million in 2018, at a CAGR of 8.3% during the forecast period.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155083837Growth in the global companion animal population, the rising incidence of veterinary dental problems, and growth in the number of veterinary practitioners and income levels in developed economies during the forecast period are the primary drivers for the Veterinary Dentistry Equipment Market during the forecast period.North America to dominate the Veterinary Dental Equipment Market in 2018North America is expected to account for the largest share of the Veterinary Dental Instruments Market in 2018, followed by Europe and the Asia Pacific.The growing number of veterinary practices, increasing number of companion animals, and rising companion animal healthcare expenditure are some of the key factors driving the growth of the Veterinary Dentistry Equipment Market in North America.The small companion animals Segment is expected to dominate the Veterinary Dental Instruments Market during the forecast period of 2018 to 2023Based on type of animal, the Veterinary Dental Dentistry Market is segmented into small companion animals and large animals.The small companion animals segment is expected to account for the largest share of the Veterinary Dental Equipment Market in 2018.The large share of this segment can be attributed to the growing companion animal population, increasing pet care expenditure, and the high prevalence of dental diseases in companion animals.The dental equipment segment to account for the largest market share in 2018On the basis of product, the Veterinary Dental Equipment Market is segmented into equipment, hand instruments, consumables, and adjuvants.The dental equipment segment is expected to account for the largest share of the Veterinary Dentistry Equipment Market in 2018.The high cost of dental equipment and the rising income level of veterinarians, resulting in the higher adoption of dental equipment, are major factors responsible for the large share of this segment.Recent Developments -In 2018, Dispomed (US) launched Highdent Quattro Plus, its latest in veterinary dental units.In 2018, Eickemeyer (Germany) signed a partnership agreement with Central CPD (UK) to connect with veterinary practitioners through professional training programs and promote the latest medical equipment.In 2015, Henry Schein (US) acquired Jorgen Kruuse A/S (Denmark) to expand the company's Animal Health business in 23 countries with a strong presence in Nordic countries.Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=155083837The prominent players in the Veterinary Dental Equipment Market are iM3 (Australia), Dentalaire Products International (US), Henry Schein, Inc. (US), Midmark Corporation (US), Dispomed (Canada), MAI Animal Health (US), Integra LifeSciences Corporation (US), Acteon Group (UK), TECHNIK Veterinary Ltd (UK), Cislak manufacturing (US), Eickemeyer (Germany), and J Instruments Inc. (US).
According to the new market research report In Vitro Toxicology Testing Market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065The major factors driving the growth of this in vitro toxicity testing market are the opposition to animal testing, technological advancements, and increasing R expenditure to detect toxicity at an early stage during drug development are the primary growth drivers for this market.Asia Pacific is estimated to be the fastest-growing market for in vitro toxicology testing during the forecast periodThe APAC in vitro toxicology testing market is projected to register the highest growth during the forecast period.Factors such as emergence of CROs for outsourcing toxicology-related research projects, opposition to animal testing resulting in the use of alternate methods, increasing pharmaceutical drug pipeline, and growing consumer awareness of product safety are some of the key factors driving the growth of the market in the APAC.In the toxicity endpoints and tests market, the organ toxicity segment is expected to grow at the highest CAGR during the forecast periodThe organ toxicity segment is expected to grow at the highest CAGR during the forecast period.The growth in this segment can be attributed to factors such as the increasing focus on drug safety and consumer-product safety, along with the need to screen potential drug targets during the early stage of drug development.Based on the technologies used in the in vitro toxicology testing, the cell culture technologies segment is expected to account for the largest share of the in vitro toxicology testing marketThe cell culture technologies segment is estimated to account for the largest market share in 2018.The large share of this segment can be attributed to the fact that it is the most preferred technique for toxicity testing, being capable of mimicking in vivo conditions.By product and service, the consumables segment is expected to account for the largest share of the in vitro toxicology testing marketThe consumables segment is estimated to account for the largest market share in 2019.The large share of this segment can be attributed to the increasing demand for high-quality reagents and the repeated use of media and reagents in in vitro toxicology studies.Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=209577065The prominent players in the in vitro toxicology testing market include Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US).
According to research report the global Genome Editing Market is projected to reach USD 6.28 billion by 2022 from USD 3.19 billion in 2017, at a CAGR of 14.5% during the forecast period.Ask For Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000The key factors propelling the growth of this genome editing market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics.In 2017, North America is projected to have the highest growth rate during the forecast period.Factors such as the development of gene therapy in the US, increasing use of genetically modified crops, rising prevalence of infectious diseases and cancer, and rising availability of research grants and funding are propelling market growth in North America.Based on technology, the genome engineering market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, Adenine Base Editor (ADE), and Jump-In).The CRISPR segment is expected to register the highest growth during the forecast period.The ease of use associated with the CRISPR technology is a significant advantage over ZFN and TALEN, especially in generating a large set of vectors to target numerous sites or even genome-wide libraries is one of the major factors driving the growth of this segment.The global genome editing market, by application, is segmented into cell line engineering, genetic engineering, and other applications (diagnostics and therapeutics).The cell line engineering segment is estimated to register the highest growth rate during the forecast period.Factors such as increasing funding from governments and private organizations, growing industry focus on stem cell research, and increasing global awareness about stem cell therapies through various organizations are driving the growth of the cell line engineering segment.Based on end user, the global genome engineering market is segmented into biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations.
1
According to the new market research report Spatial Genomics Market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period.Ask For Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551Market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications in biomarker identification and drug discovery & development, and increasing investment in biopharmaceutical R On the other hand, lack of awareness about these techniques in the emerging countries and the high cost of instruments are some factors limiting the market growth.The prominent players operating in the spatial genomics and transcriptomics market are 10X Genomics (US), NanoString Technologies Inc. (US), Illumina Inc. (US), and Bio-Rad Laboratories (US).NanoString Technologies Inc., held a dominant share in the global spatial genomics market.In 2019, the company launched the GeoMx Digital Spatial Profiler, enabling highly multiplexed spatial profiling of RNA and protein targets in various sample types, including FFPE tissue sections.The company held a substantial market share in 2019 due to its brand presence and product offerings in the spatial genomics and transcriptomics market.10X genomics held the second-largest position in the spatial genomics market in 2019.The company offers the Visium Spatial platform and consumables such as Visium Spatial Gene Expression assays and Visium mRNA arrays to measure spatial gene expression patterns using high-density DNA barcode sequencing arrays.The company acquired Spatial Transcriptomics (Sweden) in 2018 and entered the spatial genomics and transcriptomics market.Request Free Report Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170900551Illumina Inc. (US) held a leading position in the global spatial genomics market, with a share of about 12–17%.
According to research report the lab informatics market is estimated to reach USD 3.8 billion by 2024 from USD 2.6 billion in 2019, at a CAGR of 7.5% during the forecast period.Ask For Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203037633The increasing need for laboratory automation; the development of integrated lab informatics solutions; the need to comply with regulatory requirements; and the growing demand in biobanks/biorepositories, academic research institutes, and CROs are the major factors driving the growth of the laboratory informatics market.The services segment accounted for the largest share of the lab informatics market in 2018.Based on components, the healthcare laboratory informatics market is segmented into services and software.The services segment dominated this market in 2018.The large share of the services segment can be attributed to the growing technological advancements in solution offerings by various vendors, increasing adoption of cloud-based solutions, growing need for consulting services, and the recurring nature of services.Furthermore, in terms of IT usage and skill, the life science industry relies heavily on service providers.The cloud-based models segment is expected to grow at the highest CAGR during the forecast period.On the basis of deployment model, the lab informatics market is segmented into on-premise, cloud-based, and remotely hosted models.The cloud-based models segment is expected to grow at the highest CAGR during the forecast period.Factors such as on-demand self-serving analytics, no upfront capital investment for hardware, extreme capacity flexibility, and a pay-as-you-go pricing model will boost the demand for cloud-based laboratory informatics solutions in the coming years.
According to research report the interventional cardiology devices market is expected to reach USD 20.85 billion by 2022 from USD 14.52 billion in 2017, at a CAGR of 7.5%.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548Interventional cardiology devices are devices that are used to unclog blood vessels and restore normal blood flow.The market for these devices is expected to reach USD 20.85 billion by 2022 from USD 14.52 billion in 2017, at a CAGR of 7.5% during the forecast period.Growth in this market is mainly driven by factors such as the rapidly increasing geriatric population and technological advancements in interventional cardiology devices.The interventional cardiology devices market is geographically segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW).Asia Pacific is expected to register the highest growth due to the improving healthcare infrastructure, the heavy burden of cardiovascular diseases, rising healthcare expenditure, and growth in the demand for interventional cardiology devices.On the basis of type, the interventional cardiology devices market is categorized into angioplasty balloons, angioplasty stents, catheters, plaque modification devices, hemodynamic flow alteration devices, and other interventional cardiology devices.Growth in this market is mainly due to the increasing adoption of these devices for plaque removal in arteries due to their effectiveness.The angioplasty stents market is further segmented into bare-metal stents, drug-eluting stents, and bioresorbable stents.
According to research report the EMS products market is expected to reach USD 25.56 billion by 2022 from USD 19.01 billion in 2017, at a CAGR of 6.1%.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=195094847 Growth in this emergency medical services products market is primarily driven by the high demand for emergency care, increasing incidence of trauma injuries, and growing investments by government bodies on healthcare infrastructure development (including the establishment of and improvements in emergency care infrastructure).However, the high cost of emergency equipment is one of the major factors restraining the growth of this market.North America is estimated to dominate the emergency medical services products market in 2017.The large share of this regional segment can primarily be attributed to the rising number of emergency visits, rising geriatric population, increasing healthcare expenditure, improving hospital infrastructure, technological advancements, and the strong presence of major players in the region.Emergency medical procedures involve on-the-spot diagnosis and treatment of the critically ill or injured.The emergency medical services EMS products market includes medical products and equipment used for such urgent procedures.•By application, the market is segmented into cardiac care, trauma injuries, respiratory care, oncology, and other applications.
According to research report the medical image management market is projected to reach USD 4.40 billion in 2023 from USD 3.04 billion in 2018 at a CAGR of 7.7% during the forecast period.Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=240573338Technological advancements in diagnostic imaging modalities and image management software, growing investments in the medical imaging market, government initiatives to encourage EMR adoption, increasing usage of imaging equipment, growing adoption of image management systems by small hospitals and imaging centers, and rapidly growing big data in healthcare are factors driving the growth of the medical image management system market.On the other hand, budgetary constraints and longer product lifecycle of VNA may limit market growth to a certain extent during the forecast period.The PACS segment is expected to dominate the medical image management market in 2018.Based on product, the medical image management market is segmented into PACS, VNAs, AICA, and enterprise/universal viewers.The PACS segment is expected to account for the largest share of the market in 2018.Factors such as technological advancements in PACS; adoption of PACS in new imaging segments such as endoscopy, ophthalmology, mammography, and oncology; growing adoption of PACS by small hospitals and imaging centers; and government initiatives encouraging healthcare IT adoption are driving the growth of the PACS segment.The hospitals segment is expected to dominate the medical image management system market in 2018.The medical image management market is segmented on the basis of end users into hospitals, diagnostic imaging centers, and other end users including ambulatory surgical centers (ASCs), small clinics, and contract research organizations (CROs).In 2018, the hospitals segment is expected to account for the largest share of the global medical image management market.Based on procurement model, the enterprise PACS segment is projected to grow at the highest CAGR during the forecast period.By procurement model, the PACS market is segmented into departmental PACS and enterprise PACS.In 2018, the departmental PACS segment is estimated to account for the largest market share.
More

Top